LESS Medium

Hazard statements (CLP)

H317, H319, H400, H410

Code

Statements

H317

May cause an allergic skin reaction

SECTION 2: Hazards identification

According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture

Adverse physicochemical, human health and environmental effects

May cause an allergic skin reaction. Causes serious eye irritation. Very toxic to aquatic life with long lasting effects

Hazard pictograms

GHS07 GHS09

Signal word

Warning

Contains

Sodium pyruvate

Hazard statements

H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H410 - Very toxic to aquatic life with long lasting effects.

Precautionary statements

P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P321 - Specific treatment (see supplemental first aid instruction on this label). P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention. P391 - Collect spillage.

2.3 Other hazards

Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Sodium pyruvate (113-24-6), Sodium chloride (7647-14-5), Iron(II) sulfate heptahydrate regulation, in accordance with Annex XIII (7782-63-0), (-)-Riboflavin (83-88-5)(¹) Substance(s) not meeting the vPvB criteria of REACH Sodium pyruvate (113-24-6), Sodium chloride (7647-14-5), Iron(II) sulfate heptahydrate regulation, in accordance with Annex XIII (7782-63-0), (-)-Riboflavin (83-88-5)(¹) (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %

2.1 Classification of the substance or mixture

Classification according to Regulation (EC) No. 1272/2008 [CLP] Serious eye damage/eye irritation, Category 2 H319 Skin sensitisation, Category 1 H317 Hazardous to the aquatic environment – Acute Hazard, H400 Category 1 Hazardous to the aquatic environment – Chronic Hazard, H410 Category 1 Full text of H- and EUH-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause an allergic skin reaction. Causes serious eye irritation. Very toxic to aquatic life with long lasting effects. 2.2. Label elements Labelling according to Regulation (EC) No. 1272/2008 [CLP] Hazard pictograms (CLP) : GHS07 GHS09 Signal word (CLP) : Warning Contains : Sodium pyruvate Hazard statements (CLP) : H317 - May cause an allergic skin reaction. H319 - Causes serious eye irritation. H410 - Very toxic to aquatic life with long lasting effects. Precautionary statements (CLP) : P261 - Avoid breathing dust/fume/gas/mist/vapours/spray. P280 - Wear protective gloves/protective clothing/eye protection/face protection/hearing protection. P321 - Specific treatment (see supplemental first aid instruction on this label). P333+P313 - If skin irritation or rash occurs: Get medical advice/attention. P337+P313 - If eye irritation persists: Get medical advice/attention. P391 - Collect spillage. 2.3. Other hazards Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII Component Substance(s) not meeting the PBT criteria of REACH Sodium pyruvate (113-24-6), Sodium chloride (7647-14-5), Iron(II) sulfate heptahydrate regulation, in accordance with Annex XIII (7782-63-0), (-)-Riboflavin (83-88-5)(¹) Substance(s) not meeting the vPvB criteria of REACH Sodium pyruvate (113-24-6), Sodium chloride (7647-14-5), Iron(II) sulfate heptahydrate regulation, in accordance with Annex XIII (7782-63-0), (-)-Riboflavin (83-88-5)(¹) (¹) Substance(s) in concentration below 0.1 % and displayed on a voluntary basis The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 % SECTION 3: Composition/information on ingredients 3.2. Mixtures Name Product identifier % Classification according to Regulation (EC) No. 1272/2008 [CLP] Sodium pyruvate CAS-No.: 113-24-6 ≥ 10 – < 15 Eye Irrit. 2, H319 EC-No.: 204-024-4 Skin Sens. 1B, H317 Aquatic Chronic 2, H411 Sodium chloride CAS-No.: 7647-14-5 ≥ 5 – < 10 Not classified substance with national workplace exposure limit(s) EC-No.: 231-598-3 (LT, LV) Magnesium sulfate anhydrous CAS-No.: 7487-88-9 ≥ 5 – < 10 Aquatic Acute 1, H400 (M=100) EC-No.: 231-298-2 Aquatic Chronic 1, H410 (M=100) Iron(II) sulfate heptahydrate CAS-No.: 7782-63-0 ≥ 0.1 – < 0.5 Acute Tox. 4 (Oral), H302 substance with national workplace exposure limit(s) EC-No.: 231-753-5 Acute Tox. 4 (Inhalation:dust,mist), H332 (BE, GB) EC Index-No.: 026-003-01-4 Skin Irrit. 2, H315 Eye Irrit. 2, H319 (-)-Riboflavin CAS-No.: 83-88-5 < 0.1 Not classified substance with national workplace exposure limit(s) EC-No.: 201-507-1 (LT, LV) Specific concentration limits: Name Product identifier Specific concentration limits (%) Iron(II) sulfate heptahydrate CAS-No.: 7782-63-0 (25 ≤ C < 100) Skin Irrit. 2; H315 EC-No.: 231-753-5 EC Index-No.: 026-003-01-4 Full text of H- and EUH-statements: see section 16 SECTION 4: First aid measures 4.1. Description of first aid measures